← Back to all signals
RESEARCH PAPER ANALYSIS

Validation of the Distress Thermometer for detecting psychological distress in patients with stable chronic obstructive pulmonary disease: optimal cut-off score and influencing factors.

AI interpretation is pending for this paper.

Open original publication →
PMID40770718
JournalBMC pulmonary medicine
Publication Date2025-08-06
Ingested2026-08-02 12:05 AM
EXECUTIVE SUMMARY

What the AI sees

Not AI summarized yet.

WHY IT MATTERS

Research significance

Pending deeper interpretation.

ABSTRACT

Source abstract

BACKGROUND: Patients with chronic obstructive pulmonary disease (COPD) are at high risk for psychological distress, yet validated screening tools are not routinely used in clinical practice. The Distress Thermometer (DT), originally developed for cancer patients, is a brief screening tool for detecting psychological distress. However, the optimal cut-off in COPD patients remains unclear. AIM: This study aims to validate the DT for use in stable COPD patients and to explore factors influencing psychological distress. METHODS: A cross-sectional study was conducted involving 386 stable COPD patients. Data were collected using sociodemographic questionnaires, the DT, and the Hospital Anxiety and Depression scale (HADS). Receiver Operating Characteristics (ROC) analysis was employed to determine the predictive metrics of various DT cut-off scores compared to the HADS. Bivariate binary logistic regression was used to identify factors influencing psychological distress. CLINICAL TRIAL NUMBER: This cross-sectional survey study did not involve experimental interventions and therefore did not require registration in a clinical trials platform. However, the study protocol can be retrieved from https://doi.org/10.17605/OSF.IO/C3N79 . RESULTS: The mean DT reported by patients was 3.77, while the mean total HADS score was 29.68. The DT score showed a high correlation with the total HADS score (r = 0.640). An optimal DT cut-off score of ≥ 5 was identified, yielding a Youden index of 0.815, with sensitivity and specificity of 97.40% and 84.14%, respectively. Using this cut-off score, the incidence of significant psychological distress was found to be 32.1%. Risk factors for psychological distress included gender, number of children, educational level, frequency of exercise, GOLD degree, and number of acute exacerbations. CONCLUSIONS: The DT is a valid screening tool for identifying psychological distress among COPD patients. With an optimal cut-off score of ≥ 5, the DT offers high sensitivity and specificity, making it a reliable measure for clinical use. This study also highlights significant factors contributing to psychological distress, emphasizing the importance of integrating routine psychological assessments and care into the routine management of COPD to improve patient outcomes.

SUPPORTING PAPER SET

32 more papers to review

Ranked by current scoring engine
1 Predisposing, Precipitating, Perpetuating, and Protective Factors Associated With Distress in the Siblings of Children With Cancer: A Systematic Review. Journal of pediatric hematology/oncology nursing 71.4 2 Germline POT1 variants are associated with long telomeres and an unexpected broad spectrum of malignancies. Genetics in medicine open 57.0 3 Risk Factors for Pouch Neoplasia in Patients With Inflammatory Bowel Disease: A Case-Control Study. Gastro hep advances 69.0 4 Neuroblastoma Metastasis to the Mandible in Children: A Case Report and Focused Narrative Review of Reported Cases. Children (Basel, Switzerland) 57.5 5 Proteomic Profiling of Bone Marrow Aspirates from Patients with Methotrexate- and Vincristine-Resistant B-Cell Acute Lymphoblastic Leukemia: A Retrospective Analysis. Pharmaceuticals (Basel, Switzerland) 71.7 6 A Tale of Two Cohorts: Comparing HPV Vaccination Barriers and Facilitators Among HIV-Negative and HIV-Positive Women in Tennessee. International journal of environmental research and public health 60.0 7 A Sanguinarine Analogue Targeting ROS Signaling Exhibits Anti-Tumour Effects by Inducing Apoptosis and Ferroptosis in Osteosarcoma. Antioxidants (Basel, Switzerland) 74.7 8 Prepubertal Screening for Testicular Adrenal Rest Tumors in Boys with Classic Congenital Adrenal Hyperplasia: Emerging Evidence and Practical Implications. Children (Basel, Switzerland) 57.0 9 Pharmacogenetic Predictors of Chemotherapy Treatment-Related Toxicities in Paediatric and Adolescent Acute Lymphoblastic Leukemia: A Systematic Review, Meta-Analysis and Literature-Based Candidate Prioritization. Pharmaceuticals (Basel, Switzerland) 85.98 10 [Opsoclonus Myoclonus Ataxia: Diagnostic pathway and immunosuppressive treatment in opsoclonus-myoclonus]. Medicina 68.04 11 [Sturge-Weber syndrome: comparative analysis between clinical manifestations and neuro-radiological findings]. Medicina 57.6 12 Image-Based Assessment of Anti-TNF Treatment Outcomes in Pediatric CRMO/CNO: A Single-Center Case Series. Children (Basel, Switzerland) 61.84 13 Understanding HPV Vaccine Uptake Among American Indian and Alaska Native College Students: A Scoping Review. International journal of environmental research and public health 58.7 14 Genetic Susceptibility to Anthracycline-Induced Cardiotoxicity in Australian Pediatric Cancer Patients: A Case-Control Study. JACC. Advances 54.62 15 Infection-Related Adverse Events of Tisagenlecleucel in Pediatric Relapsed/Refractory B-Cell Acute Lymphoblastic Leukemia: A FAERS Pharmacovigilance Study. Children (Basel, Switzerland) 72.16 16 Catalase Defines Radiotherapy Resistance and a Therapeutic Vulnerability in Rhabdomyosarcoma. International journal of molecular sciences 64.88 17 Multidisciplinary Management of Pediatric Craniopharyngioma: From Diagnosis to Long-Term Outcomes. Biomedicines 67.4 18 Idiopathic Syringomyelia: A Systematic Scoping Review. Journal of clinical medicine 73.5 19 Beyond Oligodendroglioma: An Integrated Diagnostic Approach to CNS Tumors with Oligodendroglioma-like Morphology, with a Focus on Morphological Pitfalls, Immunoprofiles, and Molecular Signatures. International journal of molecular sciences 56.0 20 Diagnostic Intervals in Children, Adolescents and Young Adults with Primary Bone Sarcoma: A Systematic Review. Cancers 79.6 21 Next-Generation Sequencing Refines Diagnosis and Expands Precision Medicine Opportunities in Soft Tissue Sarcomas. International journal of molecular sciences 68.64 22 Closing the evidence gap: why childhood cancer research must include fathers. Public health reviews 28.5 23 Prognostic implications of CD123 in pediatric B-cell acute lymphoblastic leukemia: a single-center retrospective analysis. Frontiers in pediatrics 79.8 24 Revisiting the hematological manifestations of vitamin B12 deficiency. Frontiers in nutrition 59.9 25 Efficacy and Safety of Adjusting Antimicrobial Therapy in Episodes of Fever and Neutropenia Catalogued as Fever of Unknown Origin in Children with Cancer: A Randomized Clinical Trial. Antibiotics (Basel, Switzerland) 76.64 26 Health Economic Assessment of PM2.5 Originating from Residential Wood Combustion-A Case Study in Northern Sweden. International journal of environmental research and public health 47.7 27 Nanotechnology in Pediatric Neurology: Applications and Innovations. Pharmaceutics 77.9 28 Disparities in Area Socioeconomic Development and Pediatric Cancer Survival in Romania-A National Pediatric Registry Study on Multiple Geographic Levels. Cancers 71.62 29 Pediatric B-Cell Acute Lymphoblastic Leukemia: Comprehensive Genomic Characterization Including SNP-Array and Analysis of Relapse Risk. Cancers 64.92 30 Precision Medicine in Dermatology: MEK Inhibition and MAPK Pathway Modulation for Congenital Melanocytic Nevi. Biomedicines 70.44 31 Pancreatoblastoma: A Descriptive and Comparative Analysis with Pancreatic Ductal Adenocarcinoma Using SEER Data. Cancers 63.1 32 Cytokines in First-Episode Psychosis: Implications for Pathophysiology: A Narrative Literature Review. Brain sciences 57.0
PATIENT-FRIENDLY SUMMARY

Validation of the Distress Thermometer for detecting psychological distress in patients with stable chronic obstructive pulmonary disease: optimal cut-off score and influencing factors.

For education only—not personal medical advice.

Pediatric cancer research intelligence graphic
PEDIATRIC CANCER VISUAL SYSTEM

Open the Research Intelligence Map

Explore the active pediatric oncology analysis view.

Expand Intelligence View →
Full Pediatric cancer research intelligence graphic